1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
US6251910A · kind A · utility
14Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 1998 |
| Grant date | Jun 26, 2001 |
| Priority date | — |
| Expiry date | Sep 21, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula having the following stereochemistry ##STR1## PA1 wherein R, R.sup.1, R.sub.2, R.sup.3 and R.sup.4 are as defined in the specification. The compounds are useful as P.sub.2T receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.